AXSM

Axsome Therapeutics

Fundamental data last updated:April 13, 2026

company profile

SECTOR

Healthcare

industry

Biotechnology

Exchange

Nasdaq

County of HQ

United States

Next Earnings Date

05/04/26

Business Summary

Array Technologies designs and manufactures solar tracking systems that allow utility-scale solar panels to follow the sun and maximize energy output. The company generates revenue primarily through equipment sales to large-scale solar developers and EPC firms, with performance tied directly to solar installation cycles. Its moat, to the extent it exists, comes from engineering expertise, installed base scale, and integration into project design workflows that create switching friction once specified. Cash generation ultimately depends on volume growth in solar deployments and the company’s ability to convert revenue into positive operating margin, which is currently the core operational challenge.

VALUATION

P/E

-

Market Cap ($M USD)

$9,110

Forward P/E

29.2

PEG

-

PRICE TO SALES

13.9

PRICE TO BOOK

103.1

EV / EBITDA

-53.6

5-Year Average P/E

DIVIDEND

Yield

-

Annual Payout

-

Payout Ratio

-

Consecutive Years of Dividend Growth

0

5-Year Dividend Growth Rate

-

Financial Health & Profitability

Earnings Per Share

-$3.68

Next Year EPS Growth Estimate

$6.09

Next Year Revenue Growth Estimate

56.60%

Return on Equity (ROE)

-207.50%

Operating Margin

-26.50%

Debt-to-Equity

2.5

Piotroski F-Score

5

Altman Z-Score

6.9

Return on Invested Capital (ROIC)

-63.50%%

Current Ratio

1.6

Quick Ratio

Gainseekers Quantitative Analysis

Summary

At a $1,095M market cap with a Forward P/E of 8.3 and Price/Sales of 0.9, the market is pricing ARRY like a distressed cyclical rather than a growth technology play. The low forward multiple suggests expectations are severely depressed, yet the Altman Z-Score of 1.6 signals real balance sheet stress and non-trivial bankruptcy risk. An operating margin of -43.00% and ROIC of -8.20% confirm that capital is currently being destroyed, not compounded. This is not a clean value story; it is a balance-sheet-constrained turnaround trading at a statistically cheap earnings multiple that the market clearly does not trust.

AI Exposure / Tech Reliance

As a Solar company within the Technology sector, ARRY sits in a structurally digitizing industry where automation, AI-driven energy optimization, and grid intelligence are becoming core differentiators. The ability to integrate smart tracking systems and data-driven efficiency tools will determine long-term competitiveness. However, nothing in the current profitability profile suggests it is yet monetizing that technological positioning effectively.

The Bull Case

A deep value or GARP investor could argue the stock is pricing in catastrophe that may not materialize. A Forward P/E of 8.3 combined with a sub-1.0 Price/Sales ratio of 0.9 implies muted expectations despite 8.20% Return on Equity and a Current Ratio of 2.3, which indicates adequate short-term liquidity. The Piotroski F-Score of 4 is mediocre but not distressed, suggesting operational metrics are mixed rather than collapsing outright. If margins normalize from the current -43.00% operating level and ROIC moves from -8.20% back into positive territory, even modest execution improvement could drive multiple expansion from depressed levels.

The Bear Case

The bear case is blunt: this balance sheet is stretched and profitability is broken. Debt/Equity of 5.70% combined with an Altman Z-Score of 1.6 places the company in a financially fragile zone, while a PEG Forward of 4.4 implies investors are paying heavily relative to expected growth. Operating Margin at -43.00% and ROIC at -8.20% signal structural inefficiency, not temporary noise. With EPS Next Year estimated at -$0.73, the earnings trajectory is deteriorating, and the market’s skepticism is rational given the combination of leverage, negative returns on capital, and unstable profitability.

Market Sentiment & Smart Money

Short Interest %

6.40%

Analyst Consensus

1.27

Average Analyst Price Target

$224.90

Institutional Ownership %

75.80%

1-Year Beta

0.55

Insider Buying % (6 Mo)

15.50%%

Distance to 52-Week High

93.00%%

Distance to 52-Week Low

189.60%%